1. Home
  2. AMCX vs ATYR Comparison

AMCX vs ATYR Comparison

Compare AMCX & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMCX
  • ATYR
  • Stock Information
  • Founded
  • AMCX 1980
  • ATYR 2005
  • Country
  • AMCX United States
  • ATYR United States
  • Employees
  • AMCX N/A
  • ATYR N/A
  • Industry
  • AMCX Cable & Other Pay Television Services
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AMCX Telecommunications
  • ATYR Health Care
  • Exchange
  • AMCX Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • AMCX 275.8M
  • ATYR 290.6M
  • IPO Year
  • AMCX 2011
  • ATYR 2015
  • Fundamental
  • Price
  • AMCX $5.85
  • ATYR $3.24
  • Analyst Decision
  • AMCX Sell
  • ATYR Strong Buy
  • Analyst Count
  • AMCX 5
  • ATYR 6
  • Target Price
  • AMCX $6.50
  • ATYR $18.60
  • AVG Volume (30 Days)
  • AMCX 441.3K
  • ATYR 1.1M
  • Earning Date
  • AMCX 05-09-2025
  • ATYR 05-07-2025
  • Dividend Yield
  • AMCX N/A
  • ATYR N/A
  • EPS Growth
  • AMCX N/A
  • ATYR N/A
  • EPS
  • AMCX N/A
  • ATYR N/A
  • Revenue
  • AMCX $2,380,086,000.00
  • ATYR N/A
  • Revenue This Year
  • AMCX N/A
  • ATYR $551.06
  • Revenue Next Year
  • AMCX N/A
  • ATYR $2,144.84
  • P/E Ratio
  • AMCX N/A
  • ATYR N/A
  • Revenue Growth
  • AMCX N/A
  • ATYR N/A
  • 52 Week Low
  • AMCX $5.41
  • ATYR $1.42
  • 52 Week High
  • AMCX $18.58
  • ATYR $4.66
  • Technical
  • Relative Strength Index (RSI)
  • AMCX 39.11
  • ATYR 48.38
  • Support Level
  • AMCX $5.57
  • ATYR $3.06
  • Resistance Level
  • AMCX $6.72
  • ATYR $3.45
  • Average True Range (ATR)
  • AMCX 0.33
  • ATYR 0.24
  • MACD
  • AMCX 0.01
  • ATYR -0.01
  • Stochastic Oscillator
  • AMCX 24.35
  • ATYR 29.51

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: